4iqr › Citations

Multidomain integration in the structure of the HNF-4α nuclear receptor complex.

Chandra V, Huang P, Potluri N, Wu D, Kim Y, Rastinejad F
Nature 495 394-8 (2013)
Cited: 122 times
EuropePMC logo PMID: 23485969

Abstract

The hepatocyte nuclear factor 4α (HNF-4α; also known as NR2A1) is a member of the nuclear receptor (NR) family of transcription factors, which have conserved DNA-binding domains and ligand-binding domains. HNF-4α is the most abundant DNA-binding protein in the liver, where some 40% of the actively transcribed genes have a HNF-4α response element. These regulated genes are largely involved in the hepatic gluconeogenic program and lipid metabolism. In the pancreas HNF-4α is also a master regulator, controlling an estimated 11% of islet genes. HNF-4α protein mutations are linked to maturity-onset diabetes of the young, type 1 (MODY1) and hyperinsulinaemic hypoglycaemia. Previous structural analyses of NRs, although productive in elucidating the structure of individual domains, have lagged behind in revealing the connectivity patterns of NR domains. Here we describe the 2.9 Å crystal structure of the multidomain human HNF-4α homodimer bound to its DNA response element and coactivator-derived peptides. A convergence zone connects multiple receptor domains in an asymmetric fashion, joining distinct elements from each monomer. An arginine target of PRMT1 methylation protrudes directly into this convergence zone and sustains its integrity. A serine target of protein kinase C is also responsible for maintaining domain-domain interactions. These post-translational modifications lead to changes in DNA binding by communicating through the tightly connected surfaces of the quaternary fold. We find that some MODY1 mutations, positioned on the ligand-binding domain and hinge regions of the receptor, compromise DNA binding at a distance by communicating through the interjunctional surfaces of the complex. The overall domain representation of the HNF-4α homodimer is different from that of the PPAR-γ-RXR-α heterodimer, even when both NR complexes are assembled on the same DNA element. Our findings suggest that unique quaternary folds and interdomain connections in NRs could be exploited by small-molecule allosteric modulators that affect distal functions in these polypeptides.

Reviews - 4iqr mentioned but not cited (5)

  1. Androgen receptor: structure, role in prostate cancer and drug discovery. Tan MH, Li J, Xu HE, Melcher K, Yong EL. Acta Pharmacol Sin 36 3-23 (2015)
  2. Targeting nuclear receptors with marine natural products. Yang C, Li Q, Li Y. Mar Drugs 12 601-635 (2014)
  3. Full-length nuclear receptor allosteric regulation. Choi WJ, Haratipour Z, Blind RD. J Lipid Res 64 100406 (2023)
  4. Structural insights into the HNF4 biology. Beinsteiner B, Billas IML, Moras D. Front Endocrinol (Lausanne) 14 1197063 (2023)
  5. The protein architecture and allosteric landscape of HNF4α. Rastinejad F. Front Endocrinol (Lausanne) 14 1219092 (2023)

Articles - 4iqr mentioned but not cited (20)

  1. Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels. Tin A, Marten J, Halperin Kuhns VL, Li Y, Wuttke M, Kirsten H, Sieber KB, Qiu C, Gorski M, Yu Z, Giri A, Sveinbjornsson G, Li M, Chu AY, Hoppmann A, O'Connor LJ, Prins B, Nutile T, Noce D, Akiyama M, Cocca M, Ghasemi S, van der Most PJ, Horn K, Xu Y, Fuchsberger C, Sedaghat S, Afaq S, Amin N, Ärnlöv J, Bakker SJL, Bansal N, Baptista D, Bergmann S, Biggs ML, Biino G, Boerwinkle E, Bottinger EP, Boutin TS, Brumat M, Burkhardt R, Campana E, Campbell A, Campbell H, Carroll RJ, Catamo E, Chambers JC, Ciullo M, Concas MP, Coresh J, Corre T, Cusi D, Felicita SC, de Borst MH, De Grandi A, de Mutsert R, de Vries APJ, Delgado G, Demirkan A, Devuyst O, Dittrich K, Eckardt KU, Ehret G, Endlich K, Evans MK, Gansevoort RT, Gasparini P, Giedraitis V, Gieger C, Girotto G, Gögele M, Gordon SD, Gudbjartsson DF, Gudnason V, German Chronic Kidney Disease Study, Haller T, Hamet P, Harris TB, Hayward C, Hicks AA, Hofer E, Holm H, Huang W, Hutri-Kähönen N, Hwang SJ, Ikram MA, Lewis RM, Ingelsson E, Jakobsdottir J, Jonsdottir I, Jonsson H, Joshi PK, Josyula NS, Jung B, Kähönen M, Kamatani Y, Kanai M, Kerr SM, Kiess W, Kleber ME, Koenig W, Kooner JS, Körner A, Kovacs P, Krämer BK, Kronenberg F, Kubo M, Kühnel B, La Bianca M, Lange LA, Lehne B, Lehtimäki T, Lifelines Cohort Study, Liu J, Loeffler M, Loos RJF, Lyytikäinen LP, Magi R, Mahajan A, Martin NG, März W, Mascalzoni D, Matsuda K, Meisinger C, Meitinger T, Metspalu A, Milaneschi Y, V. A. Million Veteran Program, O'Donnell CJ, Wilson OD, Gaziano JM, Mishra PP, Mohlke KL, Mononen N, Montgomery GW, Mook-Kanamori DO, Müller-Nurasyid M, Nadkarni GN, Nalls MA, Nauck M, Nikus K, Ning B, Nolte IM, Noordam R, O'Connell JR, Olafsson I, Padmanabhan S, Penninx BWJH, Perls T, Peters A, Pirastu M, Pirastu N, Pistis G, Polasek O, Ponte B, Porteous DJ, Poulain T, Preuss MH, Rabelink TJ, Raffield LM, Raitakari OT, Rettig R, Rheinberger M, Rice KM, Rizzi F, Robino A, Rudan I, Krajcoviechova A, Cifkova R, Rueedi R, Ruggiero D, Ryan KA, Saba Y, Salvi E, Schmidt H, Schmidt R, Shaffer CM, Smith AV, Smith BH, Spracklen CN, Strauch K, Stumvoll M, Sulem P, Tajuddin SM, Teren A, Thiery J, Thio CHL, Thorsteinsdottir U, Toniolo D, Tönjes A, Tremblay J, Uitterlinden AG, Vaccargiu S, van der Harst P, van Duijn CM, Verweij N, Völker U, Vollenweider P, Waeber G, Waldenberger M, Whitfield JB, Wild SH, Wilson JF, Yang Q, Zhang W, Zonderman AB, Bochud M, Wilson JG, Pendergrass SA, Ho K, Parsa A, Pramstaller PP, Psaty BM, Böger CA, Snieder H, Butterworth AS, Okada Y, Edwards TL, Stefansson K, Susztak K, Scholz M, Heid IM, Hung AM, Teumer A, Pattaro C, Woodward OM, Vitart V, Köttgen A. Nat Genet 51 1459-1474 (2019)
  2. Multidomain integration in the structure of the HNF-4α nuclear receptor complex. Chandra V, Huang P, Potluri N, Wu D, Kim Y, Rastinejad F. Nature 495 394-398 (2013)
  3. Structure of the homodimeric androgen receptor ligand-binding domain. Nadal M, Prekovic S, Gallastegui N, Helsen C, Abella M, Zielinska K, Gay M, Vilaseca M, Taulès M, Houtsmuller AB, van Royen ME, Claessens F, Fuentes-Prior P, Estébanez-Perpiñá E. Nat Commun 8 14388 (2017)
  4. Nuclear receptor full-length architectures: confronting myth and illusion with high resolution. Rastinejad F, Ollendorff V, Polikarpov I. Trends Biochem Sci 40 16-24 (2015)
  5. The quaternary architecture of RARβ-RXRα heterodimer facilitates domain-domain signal transmission. Chandra V, Wu D, Li S, Potluri N, Kim Y, Rastinejad F. Nat Commun 8 868 (2017)
  6. Theoretical modeling of multiprotein complexes by iSPOT: Integration of small-angle X-ray scattering, hydroxyl radical footprinting, and computational docking. Huang W, Ravikumar KM, Parisien M, Yang S. J Struct Biol 196 340-349 (2016)
  7. Methods for SAXS-based structure determination of biomolecular complexes. Yang S. Adv Mater 26 7902-7910 (2014)
  8. Gain-of-Function Alleles in Caenorhabditis elegans Nuclear Hormone Receptor nhr-49 Are Functionally Distinct. Lee K, Goh GY, Wong MA, Klassen TL, Taubert S. PLoS One 11 e0162708 (2016)
  9. Differential dimerization of variants linked to enhanced S-cone sensitivity syndrome (ESCS) located in the NR2E3 ligand-binding domain. von Alpen D, Tran HV, Guex N, Venturini G, Munier FL, Schorderet DF, Haider NB, Escher P. Hum Mutat 36 599-610 (2015)
  10. Identification of candidate drugs using tensor-decomposition-based unsupervised feature extraction in integrated analysis of gene expression between diseases and DrugMatrix datasets. Taguchi YH. Sci Rep 7 13733 (2017)
  11. Structure-based prediction of transcription factor binding specificity using an integrative energy function. Farrel A, Murphy J, Guo JT. Bioinformatics 32 i306-i313 (2016)
  12. Berry Phenolic Compounds Increase Expression of Hepatocyte Nuclear Factor-1α (HNF-1α) in Caco-2 and Normal Colon Cells Due to High Affinities with Transcription and Dimerization Domains of HNF-1α. Real Hernandez LM, Fan J, Johnson MH, Gonzalez de Mejia E. PLoS One 10 e0138768 (2015)
  13. A structural signature motif enlightens the origin and diversification of nuclear receptors. Beinsteiner B, Markov GV, Erb S, Chebaro Y, McEwen AG, Cianférani S, Laudet V, Moras D, Billas IML. PLoS Genet 17 e1009492 (2021)
  14. In silico and in vitro analyses of the pathological relevance of the R258H mutation of hepatocyte nuclear factor 4α identified in maturity-onset diabetes of the young type 1. Sugawara K, Nomura K, Okada Y, Sugano A, Matsumoto M, Takarada T, Takeuchi A, Awano H, Hirota Y, Nishio H, Takaoka Y, Ogawa W. J Diabetes Investig 10 680-684 (2019)
  15. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. Chakraborty S, Rendón-Ramírez A, Ásgeirsson B, Dutta M, Ghosh AS, Oda M, Venkatramani R, Rao BJ, Dandekar AM, Goñi FM. F1000Res 2 286 (2013)
  16. Structural overview and perspectives of the nuclear receptors, a major family as the direct targets for small-molecule drugs. Li F, Song C, Zhang Y, Wu D. Acta Biochim Biophys Sin (Shanghai) 54 12-24 (2022)
  17. In Silico Identification of lncRNAs Regulating Sperm Motility in the Turkey (Meleagris gallopavo L.). Jastrzebski JP, Lipka A, Majewska M, Makowczenko KG, Paukszto L, Bukowska J, Dorocki S, Kozlowski K, Slowinska M. Int J Mol Sci 23 7642 (2022)
  18. Scalable Dual-Fluorescence Assay for Functional Interpretation of HNF-4α Missense Variants. Guo Y, Zhao J, Huang R, Xu T, Zhou K, Zheng L. Front Endocrinol (Lausanne) 13 812747 (2022)
  19. Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA. Jiang L, Liu X, Liang X, Dai S, Wei H, Guo M, Chen Z, Xiao D, Chen Y. Comput Struct Biotechnol J 21 3149-3157 (2023)
  20. The conformational dynamics of H2-H3n and S2-H6 in gating ligand entry into the buried binding cavity of vitamin D receptor. Tee WV, Ripen AM, Mohamad SB. Sci Rep 6 35937 (2016)


Reviews citing this publication (28)

  1. The nuclear receptor superfamily: A structural perspective. Weikum ER, Liu X, Ortlund EA. Protein Sci 27 1876-1892 (2018)
  2. Allosteric Modulation as a Unifying Mechanism for Receptor Function and Regulation. Changeux JP, Christopoulos A. Cell 166 1084-1102 (2016)
  3. Looking at nuclear receptors from a new angle. Helsen C, Claessens F. Mol Cell Endocrinol 382 97-106 (2014)
  4. Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer. Walesky C, Apte U. Gene Expr 16 101-108 (2015)
  5. Understanding nuclear receptor form and function using structural biology. Rastinejad F, Huang P, Chandra V, Khorasanizadeh S. J Mol Endocrinol 51 T1-T21 (2013)
  6. Retinoic acid actions through mammalian nuclear receptors. Huang P, Chandra V, Rastinejad F. Chem Rev 114 233-254 (2014)
  7. An evolving understanding of nuclear receptor coregulator proteins. Millard CJ, Watson PJ, Fairall L, Schwabe JW. J Mol Endocrinol 51 T23-36 (2013)
  8. Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation. De Bosscher K, Desmet SJ, Clarisse D, Estébanez-Perpiña E, Brunsveld L. Nat Rev Endocrinol 16 363-377 (2020)
  9. Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges. Simons SS, Edwards DP, Kumar R. Mol Endocrinol 28 173-182 (2014)
  10. Crosstalk of HNF4α with extracellular and intracellular signaling pathways in the regulation of hepatic metabolism of drugs and lipids. Lu H. Acta Pharm Sin B 6 393-408 (2016)
  11. Host Transcription Factors in Hepatitis B Virus RNA Synthesis. Turton KL, Meier-Stephenson V, Badmalia MD, Coffin CS, Patel TR. Viruses 12 E160 (2020)
  12. Advances in our structural understanding of orphan nuclear receptors. Gallastegui N, Mackinnon JA, Fletterick RJ, Estébanez-Perpiñá E. Trends Biochem Sci 40 25-35 (2015)
  13. Historical overview of nuclear receptors. Gustafsson JA. J Steroid Biochem Mol Biol 157 3-6 (2016)
  14. Allosteric modulation as a unifying mechanism for receptor function and regulation. Changeux JP, Christopoulos A. Diabetes Obes Metab 19 Suppl 1 4-21 (2017)
  15. Phospholipid regulation of the nuclear receptor superfamily. Crowder MK, Seacrist CD, Blind RD. Adv Biol Regul 63 6-14 (2017)
  16. Visualizing the Architectures and Interactions of Nuclear Receptors. Khorasanizadeh S, Rastinejad F. Endocrinology 157 4212-4221 (2016)
  17. Control of Cell Identity by the Nuclear Receptor HNF4 in Organ Pathophysiology. Dubois V, Staels B, Lefebvre P, Verzi MP, Eeckhoute J. Cells 9 E2185 (2020)
  18. Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers. Roshan-Moniri M, Hsing M, Butler MS, Cherkasov A, Rennie PS. Cancer Treat Rev 40 1137-1152 (2014)
  19. Transcriptional Regulation of CYP2D6 Expression. Pan X, Ning M, Jeong H. Drug Metab Dispos 45 42-48 (2017)
  20. Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC). Zhao P, Malik S, Xing S. Front Oncol 11 677926 (2021)
  21. Transcriptional control of energy metabolism by nuclear receptors. Scholtes C, Giguère V. Nat Rev Mol Cell Biol 23 750-770 (2022)
  22. Genetic disorders of nuclear receptors. Achermann JC, Schwabe J, Fairall L, Chatterjee K. J Clin Invest 127 1181-1192 (2017)
  23. Allosteric mechanisms of nuclear receptors: insights from computational simulations. Mackinnon JA, Gallastegui N, Osguthorpe DJ, Hagler AT, Estébanez-Perpiñá E. Mol Cell Endocrinol 393 75-82 (2014)
  24. Vitamin D and Its Receptor from a Structural Perspective. Rochel N. Nutrients 14 2847 (2022)
  25. A Review of Functional Characterization of Single Amino Acid Change Mutations in HNF Transcription Factors in MODY Pathogenesis. Çubuk H, Yalçın Çapan Ö. Protein J 40 348-360 (2021)
  26. Disruption of Tumor Suppressors HNF4α/HNF1α Causes Tumorigenesis in Liver. Teeli AS, Łuczyńska K, Haque E, Gayas MA, Winiarczyk D, Taniguchi H. Cancers (Basel) 13 5357 (2021)
  27. From glucose sensing to exocytosis: takes from maturity onset diabetes of the young. Samadli S, Zhou Q, Zheng B, Gu W, Zhang A. Front Endocrinol (Lausanne) 14 1188301 (2023)
  28. HNF4α isoforms: the fraternal twin master regulators of liver function. Radi SH, Vemuri K, Martinez-Lomeli J, Sladek FM. Front Endocrinol (Lausanne) 14 1226173 (2023)

Articles citing this publication (69)

  1. International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands. Christopoulos A, Changeux JP, Catterall WA, Fabbro D, Burris TP, Cidlowski JA, Olsen RW, Peters JA, Neubig RR, Pin JP, Sexton PM, Kenakin TP, Ehlert FJ, Spedding M, Langmead CJ. Pharmacol Rev 66 918-947 (2014)
  2. An alternate binding site for PPARγ ligands. Hughes TS, Giri PK, de Vera IM, Marciano DP, Kuruvilla DS, Shin Y, Blayo AL, Kamenecka TM, Burris TP, Griffin PR, Kojetin DJ. Nat Commun 5 3571 (2014)
  3. Structure of a biologically active estrogen receptor-coactivator complex on DNA. Yi P, Wang Z, Feng Q, Pintilie GD, Foulds CE, Lanz RB, Ludtke SJ, Schmid MF, Chiu W, O'Malley BW. Mol Cell 57 1047-1058 (2015)
  4. HNF4 Regulates Fatty Acid Oxidation and Is Required for Renewal of Intestinal Stem Cells in Mice. Chen L, Vasoya RP, Toke NH, Parthasarathy A, Luo S, Chiles E, Flores J, Gao N, Bonder EM, Su X, Verzi MP. Gastroenterology 158 985-999.e9 (2020)
  5. An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression. Qin Y, Roberts JD, Grimm SA, Lih FB, Deterding LJ, Li R, Chrysovergis K, Wade PA. Genome Biol 19 7 (2018)
  6. Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer. Chen Z, Lan X, Thomas-Ahner JM, Wu D, Liu X, Ye Z, Wang L, Sunkel B, Grenade C, Chen J, Zynger DL, Yan PS, Huang J, Nephew KP, Huang TH, Lin S, Clinton SK, Li W, Jin VX, Wang Q. EMBO J 34 502-516 (2015)
  7. Structure of the retinoid X receptor α-liver X receptor β (RXRα-LXRβ) heterodimer on DNA. Lou X, Toresson G, Benod C, Suh JH, Philips KJ, Webb P, Gustafsson JA. Nat Struct Mol Biol 21 277-281 (2014)
  8. Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes. Yu X, Yi P, Hamilton RA, Shen H, Chen M, Foulds CE, Mancini MA, Ludtke SJ, Wang Z, O'Malley BW. Mol Cell 79 812-823.e4 (2020)
  9. The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a β cell phenotype. Hamilton AJ, Bingham C, McDonald TJ, Cook PR, Caswell RC, Weedon MN, Oram RA, Shields BM, Shepherd M, Inward CD, Hamilton-Shield JP, Kohlhase J, Ellard S, Hattersley AT. J Med Genet 51 165-169 (2014)
  10. The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1. Blind RD, Sablin EP, Kuchenbecker KM, Chiu HJ, Deacon AM, Das D, Fletterick RJ, Ingraham HA. Proc Natl Acad Sci U S A 111 15054-15059 (2014)
  11. Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals. Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ichihara S, Akiyama M, Ikezaki H, Furusyo N, Shimizu S, Yamamoto K, Hirata M, Okada R, Kawai S, Kawaguchi M, Nishida Y, Shimanoe C, Ibusuki R, Takezaki T, Nakajima M, Takao M, Ozaki E, Matsui D, Nishiyama T, Suzuki S, Takashima N, Kita Y, Endoh K, Kuriki K, Uemura H, Arisawa K, Oze I, Matsuo K, Nakamura Y, Mikami H, Tamura T, Nakashima H, Nakamura T, Kato N, Matsuda K, Murakami Y, Matsubara T, Naito M, Kubo M, Kamatani Y, Shinomiya N, Yokota M, Wakai K, Okada Y, Matsuo H. Commun Biol 2 115 (2019)
  12. A naturally occurring insertion of a single amino acid rewires transcriptional regulation by glucocorticoid receptor isoforms. Thomas-Chollier M, Watson LC, Cooper SB, Pufall MA, Liu JS, Borzym K, Vingron M, Yamamoto KR, Meijsing SH. Proc Natl Acad Sci U S A 110 17826-17831 (2013)
  13. Allosteric Pathways in the PPARγ-RXRα nuclear receptor complex. Ricci CG, Silveira RL, Rivalta I, Batista VS, Skaf MS. Sci Rep 6 19940 (2016)
  14. The Common p.R114W HNF4A Mutation Causes a Distinct Clinical Subtype of Monogenic Diabetes. Laver TW, Colclough K, Shepherd M, Patel K, Houghton JA, Dusatkova P, Pruhova S, Morris AD, Palmer CN, McCarthy MI, Ellard S, Hattersley AT, Weedon MN. Diabetes 65 3212-3217 (2016)
  15. Multidomain architecture of estrogen receptor reveals interfacial cross-talk between its DNA-binding and ligand-binding domains. Huang W, Peng Y, Kiselar J, Zhao X, Albaqami A, Mendez D, Chen Y, Chakravarthy S, Gupta S, Ralston C, Kao HY, Chance MR, Yang S. Nat Commun 9 3520 (2018)
  16. Hnf4a deletion in the mouse kidney phenocopies Fanconi renotubular syndrome. Marable SS, Chung E, Adam M, Potter SS, Park JS. JCI Insight 3 (2018)
  17. Modulation of androgen receptor DNA binding activity through direct interaction with the ETS transcription factor ERG. Wasmuth EV, Hoover EA, Antar A, Klinge S, Chen Y, Sawyers CL. Proc Natl Acad Sci U S A 117 8584-8592 (2020)
  18. The palindromic DNA-bound USP/EcR nuclear receptor adopts an asymmetric organization with allosteric domain positioning. Maletta M, Orlov I, Roblin P, Beck Y, Moras D, Billas IM, Klaholz BP. Nat Commun 5 4139 (2014)
  19. Synergistic Regulation of Coregulator/Nuclear Receptor Interaction by Ligand and DNA. de Vera IMS, Zheng J, Novick S, Shang J, Hughes TS, Brust R, Munoz-Tello P, Gardner WJ, Marciano DP, Kong X, Griffin PR, Kojetin DJ. Structure 25 1506-1518.e4 (2017)
  20. Alterations in promoter interaction landscape and transcriptional network underlying metabolic adaptation to diet. Qin Y, Grimm SA, Roberts JD, Chrysovergis K, Wade PA. Nat Commun 11 962 (2020)
  21. Phosphorylated Nuclear Receptor CAR Forms a Homodimer To Repress Its Constitutive Activity for Ligand Activation. Shizu R, Osabe M, Perera L, Moore R, Sueyoshi T, Negishi M. Mol Cell Biol 37 e00649-16 (2017)
  22. Phenobarbital Meets Phosphorylation of Nuclear Receptors. Negishi M. Drug Metab Dispos 45 532-539 (2017)
  23. Molecular Basis for Autosomal-Dominant Renal Fanconi Syndrome Caused by HNF4A. Marchesin V, Pérez-Martí A, Le Meur G, Pichler R, Grand K, Klootwijk ED, Kesselheim A, Kleta R, Lienkamp S, Simons M. Cell Rep 29 4407-4421.e5 (2019)
  24. Profiling of 3696 Nuclear Receptor-Coregulator Interactions: A Resource for Biological and Clinical Discovery. Broekema MF, Hollman DAA, Koppen A, van den Ham HJ, Melchers D, Pijnenburg D, Ruijtenbeek R, van Mil SWC, Houtman R, Kalkhoven E. Endocrinology 159 2397-2407 (2018)
  25. Hepatocyte nuclear factor 4α is required for cell differentiation and homeostasis in the adult mouse gastric epithelium. Moore BD, Khurana SS, Huh WJ, Mills JC. Am J Physiol Gastrointest Liver Physiol 311 G267-75 (2016)
  26. CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor α in Human Liver. Makia NL, Goldstein JA. Mol Pharmacol 89 154-164 (2016)
  27. Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α. Rajbhandari P, Ozers MS, Solodin NM, Warren CL, Alarid ET. J Biol Chem 290 13749-13762 (2015)
  28. Bisphenol A Disrupts HNF4α-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats. Lam HM, Ho SM, Chen J, Medvedovic M, Tam NN. Endocrinology 157 207-219 (2016)
  29. Loss-of-function mutations in Zn-finger DNA-binding domain of HNF4A cause aberrant transcriptional regulation in liver cancer. Taniguchi H, Fujimoto A, Kono H, Furuta M, Fujita M, Nakagawa H. Oncotarget 9 26144-26156 (2018)
  30. RXR agonist modulates TR: corepressor dissociation upon 9-cis retinoic acid treatment. Fattori J, Campos JL, Doratioto TR, Assis LM, Vitorino MT, Polikarpov I, Xavier-Neto J, Figueira AC. Mol Endocrinol 29 258-273 (2015)
  31. Zinc Fingers and Homeoboxes 2 (Zhx2) Regulates Sexually Dimorphic Cyp Gene Expression in the Adult Mouse Liver. Creasy KT, Jiang J, Ren H, Peterson ML, Spear BT. Gene Expr 17 7-17 (2016)
  32. Allosteric interactions prime androgen receptor dimerization and activation. Wasmuth EV, Broeck AV, LaClair JR, Hoover EA, Lawrence KE, Paknejad N, Pappas K, Matthies D, Wang B, Feng W, Watson PA, Zinder JC, Karthaus WR, de la Cruz MJ, Hite RK, Manova-Todorova K, Yu Z, Weintraub ST, Klinge S, Sawyers CL. Mol Cell 82 2021-2031.e5 (2022)
  33. Two patients with HNF4A-related congenital hyperinsulinism and renal tubular dysfunction: A clinical variation which includes transient hepatic dysfunction. Numakura C, Hashimoto Y, Daitsu T, Hayasaka K, Mitsui T, Yorifuji T. Diabetes Res Clin Pract 108 e53-5 (2015)
  34. Computational Detection of Stage-Specific Transcription Factor Clusters during Heart Development. Zeidler S, Meckbach C, Tacke R, Raad FS, Roa A, Uchida S, Zimmermann WH, Wingender E, Gültas M. Front Genet 7 33 (2016)
  35. Cross-talk between the ligand- and DNA-binding domains of estrogen receptor. Huang W, Greene GL, Ravikumar KM, Yang S. Proteins 81 1900-1909 (2013)
  36. Identification of HNF4A Mutation p.T130I and HNF1A Mutations p.I27L and p.S487N in a Han Chinese Family with Early-Onset Maternally Inherited Type 2 Diabetes. Yang Y, Zhou TC, Liu YY, Li X, Wang WX, Irwin DM, Zhang YP. J Diabetes Res 2016 3582616 (2016)
  37. Letter Structure-function relationships in nuclear receptors: the facts. Moras D, Billas IM, Rochel N, Klaholz BP. Trends Biochem Sci 40 287-290 (2015)
  38. Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice. Pan X, Kent R, Won KJ, Jeong H. Drug Metab Dispos 45 346-352 (2017)
  39. Genomic Analysis of Oral Lichen Planus and Related Oral Microbiome Pathogens. Zhong EF, Chang A, Stucky A, Chen X, Mundluru T, Khalifeh M, Sedghizadeh PP. Pathogens 9 E952 (2020)
  40. ROCK inhibition enhances microRNA function by promoting deadenylation of targeted mRNAs via increasing PAIP2 expression. Yoshikawa T, Wu J, Otsuka M, Kishikawa T, Ohno M, Shibata C, Takata A, Han F, Kang YJ, Chen CY, Shyu AB, Han J, Koike K. Nucleic Acids Res 43 7577-7589 (2015)
  41. Ligand induced dissociation of the AR homodimer precedes AR monomer translocation to the nucleus. Shizu R, Yokobori K, Perera L, Pedersen L, Negishi M. Sci Rep 9 16734 (2019)
  42. Comprehensive screening for monogenic diabetes in 89 Japanese children with insulin-requiring antibody-negative type 1 diabetes. Ushijima K, Fukami M, Ayabe T, Narumi S, Okuno M, Nakamura A, Takahashi T, Ihara K, Ohkubo K, Tachikawa E, Nakayama S, Arai J, Kikuchi N, Kikuchi T, Kawamura T, Urakami T, Hata K, Nakabayashi K, Matsubara Y, Amemiya S, Ogata T, Yokota I, Sugihara S, Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes. Pediatr Diabetes 19 243-250 (2018)
  43. A phosphorylation-deficient mutant of retinoid X receptor α at Thr 167 alters fasting response and energy metabolism in mice. Sueyoshi T, Sakuma T, Shindo S, Fashe M, Kanayama T, Ray M, Moore R, Negishi M. Lab Invest 99 1470-1483 (2019)
  44. Co-encapsulation of HNF4α overexpressing UMSCs and human primary hepatocytes ameliorates mouse acute liver failure. Kong D, Xu H, Chen M, Yu Y, Qian Y, Qin T, Tong Y, Xia Q, Hang H. Stem Cell Res Ther 11 449 (2020)
  45. Exo70 is transcriptionally up-regulated by hepatic nuclear factor 4α and contributes to cell cycle control in hepatoma cells. Zhao Y, Hou J, Mi P, Mao L, Xu L, Zhang Y, Xiao L, Cao H, Zhang W, Zhang B, Song G, Hu T, Zhan YY. Oncotarget 7 9150-9162 (2016)
  46. Integrated Structural Modeling of Full-Length LRH-1 Reveals Inter-domain Interactions Contribute to Receptor Structure and Function. Seacrist CD, Kuenze G, Hoffmann RM, Moeller BE, Burke JE, Meiler J, Blind RD. Structure 28 830-846.e9 (2020)
  47. Monitoring Solution Structures of Peroxisome Proliferator-Activated Receptor β/δ upon Ligand Binding. Schwarz R, Tänzler D, Ihling CH, Sinz A. PLoS One 11 e0151412 (2016)
  48. ErbB3-binding protein 1 (EBP1) represses HNF4α-mediated transcription and insulin secretion in pancreatic β-cells. Han EH, Singh P, Lee IK, Urrutia R, Chi YI. J Biol Chem 294 13983-13994 (2019)
  49. Steroid receptor-coregulator transcriptional complexes: new insights from CryoEM. Yi P, Yu X, Wang Z, O'Malley BW. Essays Biochem 65 857-866 (2021)
  50. Letter Clinical heterogeneity of abnormal glucose homeostasis associated with the HNF4A R311H mutation. Delvecchio M, Di Paola R, Mangiacotti D, Sacco M, Menzaghi C, Trischitta V. Ital J Pediatr 40 58 (2014)
  51. Chemical Starting Matter for HNF4α Ligand Discovery and Chemogenomics. Meijer I, Willems S, Ni X, Heering J, Chaikuad A, Merk D. Int J Mol Sci 21 E7895 (2020)
  52. Hepatic PRMT1 ameliorates diet-induced hepatic steatosis via induction of PGC1α. Xu L, Huang Z, Lo TH, Lee JTH, Yang R, Yan X, Ye D, Xu A, Wong CM. Theranostics 12 2502-2518 (2022)
  53. Conformational Changes of RORγ During Response Element Recognition and Coregulator Engagement. Strutzenberg TS, Zhu Y, Novick SJ, Garcia-Ordonez RD, Doebelin C, He Y, Chang MR, Kamenecka TM, Edwards DP, Griffin PR. J Mol Biol 433 167258 (2021)
  54. HNF4a transcription is a target of trichloroethylene toxicity in the embryonic mouse heart. Chen S, Lencinas A, Nunez M, Selmin OI, Runyan RB. Environ Sci Process Impacts 22 824-832 (2020)
  55. Hidden modes of DNA binding by human nuclear receptors. Bhimsaria D, Rodríguez-Martínez JA, Mendez-Johnson JL, Ghoshdastidar D, Varadarajan A, Bansal M, Daniels DL, Ramanathan P, Ansari AZ. Nat Commun 14 4179 (2023)
  56. Non-canonical pattern recognition of a pathogen-derived metabolite by a nuclear hormone receptor identifies virulent bacteria in C. elegans. Peterson ND, Tse SY, Huang QJ, Wani KA, Schiffer CA, Pukkila-Worley R. Immunity 56 768-782.e9 (2023)
  57. Quaternary glucocorticoid receptor structure highlights allosteric interdomain communication. Postel S, Wissler L, Johansson CA, Gunnarsson A, Gordon E, Collins B, Castaldo M, Köhler C, Öling D, Johansson P, Fröderberg Roth L, Beinsteiner B, Dainty I, Delaney S, Klaholz BP, Billas IML, Edman K. Nat Struct Mol Biol 30 286-295 (2023)
  58. Letter Response to Moras et al. Rastinejad F, Ollendorff V, Polikarpov I. Trends Biochem Sci 40 290-292 (2015)
  59. Study of novel androgen receptor V770 variant in androgen insensitivity syndrome patients reveals the transitional state of the androgen receptor ligand binding domain homodimer. Helsen C, Rocca MS, Nguyen TT, Eerlings R, Lee XY, De Block S, Vinanzi C, Di Millo F, Giagulli V, Voet A, Ferlin A, Claessens F. Protein Sci 32 e4599 (2023)
  60. A Novel Mechanism of Coactivator Recruitment by the Nurr1 Nuclear Receptor. Daffern N, Radhakrishnan I. J Mol Biol 434 167718 (2022)
  61. Berberine retarded the growth of gastric cancer xenograft tumors by targeting hepatocyte nuclear factor 4α. Li LL, Peng Z, Hu Q, Xu LJ, Zou X, Huang DM, Yi P. World J Gastrointest Oncol 14 842-857 (2022)
  62. Case Reports Expanding the p.(Arg85Trp) Variant-Specific Phenotype of HNF4A: Features of Glycogen Storage Disease, Liver Cirrhosis, Impaired Mitochondrial Function, and Glomerular Changes. Grassi M, Laubscher B, Pandey AV, Tschumi S, Graber F, Schaller A, Janner M, Aeberli D, Hewer E, Nuoffer JM, Gautschi M. Mol Syndromol 14 347-361 (2023)
  63. Helping nephrologists find answers: hyperinsulinism and tubular dysfunction: Answers. Betcherman L, Lemaire M, Licht C, Chitayat D, Harrington J, Noone D. Pediatr Nephrol 35 257-260 (2020)
  64. Heterodimeric DNA motif synthesis and validations. Wong KC, Lin J, Li X, Lin Q, Liang C, Song YQ. Nucleic Acids Res 47 1628-1636 (2019)
  65. Identification and precision therapy for three maturity-onset diabetes of the young (MODY) families caused by mutations in the HNF4A gene. Zhang J, Jiang Y, Li J, Zou H, Yin L, Yang Y, Yang L. Front Endocrinol (Lausanne) 14 1237553 (2023)
  66. Integrative analysis reveals structural basis for transcription activation of Nurr1 and Nurr1-RXRα heterodimer. Zhao M, Wang N, Guo Y, Li J, Yin Y, Dong Y, Zhu J, Peng C, Xu T, Liu J. Proc Natl Acad Sci U S A 119 e2206737119 (2022)
  67. Molecular modeling and molecular dynamics simulation studies on thyroid hormone receptor from Rattus norvegicus: role of conserved water molecules. Mukherjee S, Dasgupta S, Adhikari U, Panja SS. J Mol Model 27 126 (2021)
  68. Recognition of fold- and function-specific sites in the ligand-binding domain of the thyroid hormone receptor-like family. Verma S, Chakraborti S, Singh OP, Pande V, Dixit R, Pandey AV, Pandey KC. Front Endocrinol (Lausanne) 13 981090 (2022)
  69. Transcription factor HNF4α2 promotes osteogenesis and prevents bone abnormalities in mice with renal osteodystrophy. Martinez-Calle M, Courbon G, Hunt-Tobey B, Francis C, Spindler J, Wang X, Dos Reis LM, Martins CS, Salusky IB, Malluche H, Nickolas TL, Moyses RM, Martin A, David V. J Clin Invest 133 e159928 (2023)


Quick links